Learning Center Articles

Weijun Wang, Jinfang Zhao, Wenfang Gui, Dan Sun, Haijiang Dai, Li Xiao, Huikuan Chu, Fan Du , Qingjing Zhu, Bernd Schnabl, Kai Huang, Ling Yang and Xiaohua Hou.

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. TUDCA improved intestinal barrier function by increasing levels of tight junction molecules and the solid chemical barrier.